Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07315282

The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese Women

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Nicole Stoffel · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The study will be a randomized, double-blind, 17-day metabolic intervention trial including 14 days of high-dose or low-dose iron supplementation. A total of 70 overweight or obese (OW/OB) women will be enrolled. Participants will be individually randomized into either the high-iron or low-iron group. Women in the low-iron group will receive 15 mg of iron as ferrous fumarate daily for 14 days, while women in the high-iron group will receive 195 mg of iron as ferrous sulfate daily for 14 days. The study consists of three visits in total. On Day 0, a fasting blood sample will be collected and an OGTT will be performed, with additional blood samples collected at 1 hour and 2 hours post-OGTT. The OGTT will be repeated on Day 14, after 14 days of oral iron supplementation, and again on Day 17, four days after oral iron supplementation has been stopped

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT195 mg iron daily3 x 65 mg iron as ferrous sulfate
DIETARY_SUPPLEMENT15 mg iron daily3 x 5 mg iron as ferrous sulfate

Timeline

Start date
2025-12-23
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2026-01-02
Last updated
2026-01-02

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT07315282. Inclusion in this directory is not an endorsement.